Age at diagnosis of breast cancer, years - median (range) |
36.5 (28–40) |
- |
BRCA gene mutation |
|
|
No |
8 |
17.4 |
Yes, BRCA 1 |
1 |
2.2 |
Yes, BRCA 2 |
0 |
0.0 |
Unknown |
37 |
80.4 |
Breast tumor localization |
|
|
Left |
23 |
50.0 |
Right |
21 |
45.7 |
Both |
2 |
4.3 |
Most extensively performed breast surgery |
|
|
Needle biopsy |
4 |
8.7 |
Breast conserving surgery |
15 |
32.6 |
Mastectomy |
27 |
58.7 |
Breast tumor histological subtype |
|
|
Ductal |
36 |
78.2 |
Lobular |
5 |
10.9 |
Ductolobular |
5 |
10.9 |
Scarff-Bloom-Richardson grade |
|
|
I |
4 |
8.7 |
II |
19 |
41.3 |
III |
15 |
32.6 |
Unknown |
8 |
17.4 |
Estrogen receptor |
|
|
Negative |
5 |
10.9 |
Positive |
41 |
89.1 |
Progesterone receptor |
|
|
Negative |
8 |
17.4 |
Positive |
38 |
82.6 |
Her2/neu receptor |
|
|
Negative |
38 |
82.6 |
Positive |
8 |
17.4 |
Tumor stage |
|
|
T1 |
11 |
23.9 |
T2 |
24 |
52.2 |
T3 |
7 |
15.2 |
T4 |
4 |
8.7 |
Nodal stage |
|
|
N0 |
14 |
30.4 |
N1 |
12 |
26.1 |
N2 |
10 |
21.7 |
N3 |
10 |
21.7 |
Distant metastasis |
|
|
cM0 |
39 |
84.8 |
cM1 |
7 |
15.2 |
Age at diagnosis of ovarian metastases, years - median (range) |
40.0 (31–51) |
- |
Time between breast cancer and ovarian metastases, months - median (range) |
41.9 (0.3–141.8) |
- |
Recurrent disease prior to oophorectomy |
|
|
No |
15 |
32.6 |
Yes, locoregional recurrence |
12 |
26.1 |
Yes, distant recurrence |
19 |
41.3 |
Type of ovarian surgery |
|
|
Unilateral oophorectomy |
0 |
0.0 |
Bilateral oophorectomy |
46 |
100.0 |
Indication for oophorectomy |
|
|
Prophylactic because of breast cancer |
9 |
19.6 |
Therapeutic because of breast cancer |
25 |
54.3 |
Abnormal ovaries on ultrasound |
12 |
26.1 |
Localization of ovarian metastases |
|
|
Left |
4 |
8.7 |
Right |
6 |
13.0 |
Both |
29 |
63.0 |
Unknown |
7 |
15.2 |